Literature DB >> 31939069

Effect of Dolutegravir and Sertraline on the Blood Brain Barrier (BBB).

Qing Ma1, Giovanni Schifitto2, Charles Venuto2, Andrew Ocque1, Stephen Dewhurst3, Gene D Morse1, Ravikumar Aalinkeel4, Stanley A Schwartz4, Supriya D Mahajan5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31939069      PMCID： PMC7141951          DOI： 10.1007/s11481-020-09904-z

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN： 1557-1890            Impact factor:   4.147


× No keyword cloud information.
  9 in total

Review 1.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

Review 2.  Structure and function of the blood-brain barrier.

Authors:  N Joan Abbott; Adjanie A K Patabendige; Diana E M Dolman; Siti R Yusof; David J Begley
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

3.  Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice.

Authors:  Mark G J de Boer; Guido E L van den Berk; Natasja van Holten; Josephine E Oryszcyn; Willemien Dorama; Daoud Ait Moha; Kees Brinkman
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

4.  Neuropsychiatric events and dolutegravir in HIV patients: a worldwide issue involving a class effect.

Authors:  Farid Kheloufi; Quentin Boucherie; Olivier Blin; Joelle Micallef
Journal:  AIDS       Date:  2017-07-31       Impact factor: 4.177

Review 5.  Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir.

Authors:  Mackenzie L Cottrell; Tanja Hadzic; Angela D M Kashuba
Journal:  Clin Pharmacokinet       Date:  2013-11       Impact factor: 6.447

6.  Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.

Authors:  C Hoffmann; T Welz; M Sabranski; M Kolb; E Wolf; H-J Stellbrink; C Wyen
Journal:  HIV Med       Date:  2016-11-10       Impact factor: 3.180

7.  Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro.

Authors:  Magdalena von Wedel-Parlow; Philipp Wölte; Hans-Joachim Galla
Journal:  J Neurochem       Date:  2009-07-25       Impact factor: 5.372

8.  Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier.

Authors:  Majid Iqbal; Hay Lam Ho; Sophie Petropoulos; Vasilis G Moisiadis; William Gibb; Stephen G Matthews
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

9.  Excess burden of depression among HIV-infected persons receiving medical care in the united states: data from the medical monitoring project and the behavioral risk factor surveillance system.

Authors:  Ann N Do; Eli S Rosenberg; Patrick S Sullivan; Linda Beer; Tara W Strine; Jeffrey D Schulden; Jennifer L Fagan; Mark S Freedman; Jacek Skarbinski
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240
  9 in total
  1 in total

Review 1.  Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications.

Authors:  Ning O Zhao; Natasha Topolski; Massimo Tusconi; Erika M Salarda; Christopher W Busby; Camila N N C Lima; Anilkumar Pillai; Joao Quevedo; Tatiana Barichello; Gabriel R Fries
Journal:  Brain Behav Immun Health       Date:  2022-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.